Thirty patients with metastatic renal cell cancer were treated by renal infarction, followed by delayed nephrectomy. All cases were collected over an eighteen-month period, with a minimum follow-up of one year. There were no complete remissions and only one partial remission, which lasted twenty-one months before progression of disease. Three patients had stable disease for at least six months,...

BACKGROUND: Hormonal contraceptive therapy is considered the easiest and most convenient method. Commercially, available combination differs in their composition concentration of combined constituents. These variations make some these products preferred over others by consumers based on side effects profile. AIM: The objective current research was to ascertain proinflammatory influences commerc...

BACKGROUND Women who are not exclusively breastfeeding are at risk of pregnancy after four to six weeks of childbirth. Postpartum contraceptive use is crucial to prevent unintended pregnancy, and to have spaced births. The study was conducted to determine the magnitude of modern contraceptive utilization and factors associated with it among lactating women in Ganta-Afeshum district. METHODS A...

BACKGROUND In 2009, approximately 410,000 teens aged 15-19 years gave birth in the United States, and the teen birth rate remains higher than in other developed countries. METHODS To describe U.S. trends in teen births and related factors, CDC used data on 1) teen birth rates during 1991-2009 from the National Vital Statistics System, 2) sexual intercourse and contraceptive use among high sch...

Medroxyprogesterone acetate (MPA: Depo-Provera) is a long-acting synthetic progestin that has been used as a contraceptive for more than 11 million women-years in 80 nations [1]. The U.S. Food and Drug Administration has denied approval of MPA as a contraceptive because of concern about its safety, especially teratogenicity and carcinogenicity [2.3]. In addition to its contraceptive action, MPA...